Showing results (1841-1850 of 5,920) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|June 8, 2019
Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohortClementina López-Medina, Maxime Dougados, Adeline Ruyssen-Witrand, et al.
Arthritis Research & Therapy|June 27, 2019
Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management interventionAbena A Twumasi, Anna Shao, Charmayne Dunlop-Thomas, et al.
Arthritis Research & Therapy|June 28, 2019
Hand exercise for women with rheumatoid arthritis and decreased hand function: an exploratory randomized controlled trialKaren Ellegaard, Cecilie von Bülow, Alice Røpke, et al.
Arthritis Research & Therapy|February 4, 2022
Ultrasound-guided lymph node biopsy sampling to study the immunopathogenesis of rheumatoid arthritis: a well-tolerated valuable research toolRenée H Fiechter, Janne W Bolt, Marleen G H van de Sande, et al.
Arthritis Research & Therapy|February 15, 2022
Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor-induced activation of intermediate monocytes in synovial fluid mononuclear cells from patients with inflammatory arthritisAnne Sofie Sørensen, Morten Nørgaard Andersen, Kristian Juul-Madsen, et al.
Arthritis Research & Therapy|February 10, 2022
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertensionKathleen D Kolstad, Avani Khatri, Michele Donato, et al.
Arthritis Research & Therapy|February 13, 2022
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antiviralsQianyu Guo, Jinfang Gao, Jiaoniu Duan, et al.
Arthritis Research & Therapy|February 13, 2022
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritisJonas Sagard, Tor Olofsson, Elisabeth Mogard, et al.
Arthritis Research & Therapy|April 2, 2022
Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE)Seerapani Gopaluni, Rona Smith, Donna Goymer, et al.
Arthritis Research & Therapy|March 22, 2022
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisM Elaine Husni, Atul Deodhar, Sergio Schwartzman, et al.
Pageof 592